Multidrug resistance (MDR) is a major obstacle in the treatment of human cancer with chemotherapy and it is attributed to ABC transporter proteins, which behave as an energy-dependent efflux pump of anticancer agents. The gene discussed is ABCG2; the disease is cancer.